Details for Patent: 6,488,960
✉ Email this page to a colleague
Summary for Patent: 6,488,960
Title: | Corticosteroid formulation |
Abstract: | The present invention pertains to a unit dose formulation comprising 0.25 to 2 mg of a corticosteroid. This small dose can be used to treat rheumatoid arthritis, especially if adapted to release at least 90% by weight of the corticosteroid, 2 to 8 hours after administration. |
Inventor(s): | Bardsley; Hazel Judith (Cambridge, GB) |
Assignee: | Arakis Ltd. (GB) |
Application Number: | 09/936,586 |
Patent Claim Types: see list of patent claims | Formulation; Compound; Use; |
Drugs Protected by US Patent 6,488,960
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 6,488,960
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
United Kingdom | 9905898 | Mar 15, 1999 |
PCT Information | |||
PCT Filed | March 14, 2000 | PCT Application Number: | PCT/GB00/00924 |
PCT Publication Date: | September 21, 2000 | PCT Publication Number: | WO00/54780 |
International Family Members for US Patent 6,488,960
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 3179000 | ⤷ Sign Up | |||
Australia | 771088 | ⤷ Sign Up | |||
Australia | 8789501 | ⤷ Sign Up | |||
Canada | 2361503 | ⤷ Sign Up | |||
Canada | 2422991 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |